Labshake search

1 - 16 of 16 citations for 5 Pyrimidinecarbonitrile 1 2R 2 3 dihydroxypropyl 1 2 3 4 tetrahydro 3 methyl 2 4 dioxo 9CI since 2019

• Deciphering the tumor-specific immunopeptidome in vivo with genetically engineered mouse models

  Alex M. Jaeger, et al., bioRxiv - Cancer Biology 2021

  Quote: ... 3 µM CHIR99021 (AbMole), 1 µM PD0325901(AbMole)] ...
• A multiplexed bioluminescent reporter for sensitive and non-invasive tracking of DNA double strand break repair dynamics in vitro and in vivo

  Jasper Che-Yung Chien, et al., bioRxiv - Genetics 2020

  Quote: ... and solutions of B02 (2×10-2 M; Abmole) and CAY10566 (CAY ...
• The dynamic interplay between ATP/ADP levels and autophagy sustain neuronal migration in vivo

  Bressan Cedric, et al., bioRxiv - Neuroscience 2020

  Quote: ... GM6001 (100 μM, Abmole, #M2147-10MG, CAS: 142880-36-2), BDNF (10 nM ...
• MIF Regulates M1 Macrophage Polarization via CD74/CXCR2/JNK Pathway and Mediates Aortic Dissection in Mice

  Lu Wang, et al., bioRxiv - Molecular Biology 2023

  Quote: ... for 2 weeks and subcutaneous injection of Angiotensin II (Abmole, USA) twice on day 15 ...
• Self-organization of Tissue Growth by Interfacial Mechanical Interactions in Multi-layered Systems

  Tailin Chen, et al., bioRxiv - Biophysics 2021

  Quote: ... Culture is DMEM with 2% chick serum and 10% FBS along with pharmacological agents NSC23766 (Abmole, 20 μM), RGD (Abcam ...
• Deciphering the tumor-specific immunopeptidome in vivo with genetically engineered mouse models

  Alex M. Jaeger, et al., bioRxiv - Cancer Biology 2021

  Quote: ... 1 µM PD0325901(AbMole)] ...
• TaBln1 negatively regulates wheat resistance to stripe rust by reducing Ca²⁺ influx

  Shuangyuan Guo, et al., bioRxiv - Pathology 2021

  Quote: ... 1 mM luciferin (AbMole) was sprayed onto the inoculated leaves ...
• MIF Regulates M1 Macrophage Polarization via CD74/CXCR2/JNK Pathway and Mediates Aortic Dissection in Mice

  Lu Wang, et al., bioRxiv - Molecular Biology 2023

  Quote: ... We used the MIF antagonist ISO-1 (Abmole, USA) to inhibit MIF expression level in mice.
• Behavioral-transcriptomic landscape of engineered T cells targeting human cancer organoids

  Johanna F. Dekkers, et al., bioRxiv - Cancer Biology 2021

  Quote: ... 5 μM Y-27632 (Abmole), 5 nM Heregulin β-1 (Peprotech) ...
• miR-203 drives breast cancer cell differentiation

  Nuria G. Martínez-Illescas, et al., bioRxiv - Cancer Biology 2023

  Quote: ... 5 μM Y-27632 (Abmole); 500 nM SB202190 (Sigma S7067) ...
• Expression and molecular regulation of key genes during adipogenesis of neural crest stem cells

  Bo-wen Dong, et al., bioRxiv - Developmental Biology 2023

  Quote: ... insulin (5 mg/mL, AbMole), isobutylmethylxanthine (0.4 moL/L ...
• Cancer associated fibroblasts mitigate the efficacy of the combination of chemotherapy and BCL-xL targeting in triple negative breast cancer cells

  Lisa Nocquet, et al., bioRxiv - Cancer Biology 2023

  Quote: ... 5⍰μM Y-27632 (AbMole), 5⍰nM Heregulin β-1 (Peprotech) ...
• Establishment and characterization of a new Pseudomonas aeruginosa infection model using 2D airway organoids and dual RNA sequencing

  Cayetano Pleguezuelos-Manzano, et al., bioRxiv - Microbiology 2023

  Quote: ... 5□μM Y-27632 (Abmole; Y-27632), 1□μM SB202190 (Sigma-Aldrich ...
• Single-cell transcription mapping of murine and human mammary organoids responses to female hormones

  Jenelys Ruiz Ortiz, et al., bioRxiv - Developmental Biology 2023

  Quote: ... 5 μmol/L Y-27632 (Abmole, Y-27632), 500 nmol/L SB202190 (Sigma ...
• TRAF6 modulates PD-L1 expression through YAP1-TFCP2 signaling in melanoma

  Xiaoyan Liu, et al., bioRxiv - Cancer Biology 2022

  Quote: ... Melanoma cells were cultured with the lentiviral solution for 24 h in the presence of 1 μg/mL polybrene (Abmole, USA). After Blasticidin screening for 72 h ...
• Vesicle-mediated mitochondrial clearance underlies an actionable metabolic vulnerability in triple-negative breast cancer

  Jody Vykoukal, et al., bioRxiv - Cancer Biology 2024

  Quote: ... and mice were randomized into treatment groups: (n=7) daily oral gavage of 60 mg kg−1 of eliglustat (AbMole BioScience, M9733) or (n=7 ...